These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7587750)

  • 1. Heterogeneity of malignant tumors should be considered when performing flow cytometric DNA analysis.
    Zhang XH; Xie TX
    Cytometry; 1995 Jun; 22(2):158-9. PubMed ID: 7587750
    [No Abstract]   [Full Text] [Related]  

  • 2. Flow cytometric analysis of nuclear DNA heterogeneity in gastric cancer.
    Imada T; Yamamoto Y; Fukuzawa K; Rino Y; Suda T; Moriwaki Y; Akiyama H; Doi T; Kito F; Takemura H
    Jpn J Clin Oncol; 1997 Aug; 27(4):221-6. PubMed ID: 9379507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral heterogeneity of DNA ploidy in breast carcinomas: a flow cytometric assessment of sampling techniques.
    Schvimer M; Lash RH; Katzin WE
    Cytometry; 1995 Dec; 22(4):292-6. PubMed ID: 8749779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA analysis of in situ ductal carcinoma of the breast via flow cytometry.
    Ottesen GL; Christensen IJ; Larsen JK; Christiansen J; Hansen B; Andersen JA
    Cytometry; 1995 Sep; 22(3):168-76. PubMed ID: 8556947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Flow cytometric analysis of the DNA content of the urinary bladder cancers--study on the DNA heterogeneity in bladder cancers].
    Toyota K; Nagamori S; Kashiwagi A; Nonomura K; Koyanagi T
    Nihon Hinyokika Gakkai Zasshi; 1995 Aug; 86(8):1353-9. PubMed ID: 7474619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric analysis of stemline heterogeneity.
    Mellin W; Grundmann E
    Pathol Res Pract; 1988 Dec; 184(1):6-10. PubMed ID: 3231571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of salivary gland tumors studied by flow cytometry.
    Tytor M; Gemryd P; Wingren S; Grenko RT; Lundgren J; Lundquist PG; Nordenskjöld B
    Head Neck; 1993; 15(6):514-21. PubMed ID: 8253558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor heterogeneity: the Lernaean hydra of oncology?
    Janiszewska M; Beca F; Polyak K
    Oncology (Williston Park); 2014 Sep; 28(9):781-2, 784. PubMed ID: 25224477
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor heterogeneity is fundamental to the tumor ecosystem.
    Heppner GH; Shekhar M
    Oncology (Williston Park); 2014 Sep; 28(9):780-1. PubMed ID: 25224476
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor heterogeneity and implications for clinical practice.
    Chu E
    Oncology (Williston Park); 2014 Sep; 28(9):726, 741. PubMed ID: 25224470
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of image analysis of imprints with flow cytometry for DNA analysis of solid tumors.
    Claud RD; Weinstein RS; Howeedy A; Straus AK; Coon JS
    Mod Pathol; 1989 Sep; 2(5):463-7. PubMed ID: 2813345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric analysis of DNA heterogeneity in superficial carcinoma of the esophagus.
    Haraguchi Y; Baba M; Takao S; Yoshinaka H; Hase S; Aikou T
    Cancer; 1995 Feb; 75(4):914-9. PubMed ID: 7842411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The need for improvement in flow cytometric analysis of ploidy and S-phase fraction.
    Frierson HF
    Am J Clin Pathol; 1991 Apr; 95(4):439-41. PubMed ID: 2014768
    [No Abstract]   [Full Text] [Related]  

  • 14. Geographic distribution of co-dominant DNA stemlines in breast carcinoma.
    Visscher D; Dolan P; Ottosen S; Crissman J
    Cytometry; 1995 Sep; 21(1):14-7. PubMed ID: 8529464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is DNA aneuploidy a marker of malignant growth?].
    Klemi PJ; Joensuu H
    Duodecim; 1988; 104(7):504-9. PubMed ID: 3049022
    [No Abstract]   [Full Text] [Related]  

  • 16. [Flow cytometric DNA analysis of pediatric solid tumor].
    Taniguchi K; Hamazaki M
    Rinsho Byori; 1990 Sep; 38(9):1059-66. PubMed ID: 2172599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Flow cytometric analysis of chromosome aberration on tumor cells].
    Akagi K; Tanaka Y
    Nihon Rinsho; 1992 Oct; 50(10):2489-96. PubMed ID: 1447821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [DNA stemline heterogeneity as preoperative prognostic factor in esophageal cancer].
    Etoh K; Kaketani K; Saito T; Uchino S; Shimoda K; Miyahara M; Kobayashi M
    Gan To Kagaku Ryoho; 1994 May; 21 Suppl 1():1-5. PubMed ID: 8203920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of flow cytometric immunophenotyping and DNA analysis for detection of malignant cells in serosal cavity fluids.
    Sayed DM; el-Attar MM; Hussein AA
    Diagn Cytopathol; 2009 Jul; 37(7):498-504. PubMed ID: 19217060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric DNA patterns from colorectal cancers--how reproducible are they?
    Scott NA; Grande JP; Weiland LH; Pemberton JH; Beart RW; Lieber MM
    Mayo Clin Proc; 1987 May; 62(5):331-7. PubMed ID: 3573821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.